Duke University

Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day

Retrieved on: 
木曜日, 4月 25, 2024
FDA, Fitness & Nutrition, Clinical Trials, Biotechnology, Other Health, Health, Pharmaceutical, General Health, Optical, Retina, USP, EDT, Retinitis pigmentosa, Food, Research, Alcoholic hepatitis, RASP, Spleen, Development, Obesity, Duke University, Liver, Patient, Erosion, Fibrosis, Multimedia, Assistant, Clinical trial, Atopic dermatitis, Therapy, Quality of life, Pharmaceutical industry

View the full release here: https://www.businesswire.com/news/home/20240425445928/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240425445928/en/
    Aldeyra will present new preclinical data from investigational RASP modulators in animal models for obesity, atopic dermatitis, inflammatory pain, and alcoholic hepatitis.
  • In the diet-induced model of obesity, ADX-629 decreased weight and fat mass alone and in combination with a GLP-1 agonist.
  • In the carrageenan model of inflammatory pain, ADX-246 increased tolerance to mechanical and thermal pain, and decreased joint swelling.
  • Consistent with previously released data from ADX-629 in a model of alcoholic hepatitis, ADX-246 reduced levels of fibrosis and fat in liver.

Great Neck Realty Co. to Auction IP Assets of BOA Nutrition, Inc., a US-Based Sports Nutrition & Wellness Company

Retrieved on: 
火曜日, 4月 23, 2024
Construction & Property, General Sports, Sports, Wine & Spirits, Fitness & Nutrition, Specialty, Health, Retail, Other Construction & Property, Sale, Caffeine, Bankruptcy, EDT, Learning, Trustee, Electrolyte, Exercise, Duke University, BOA, Chapter Seven, Court, Sodium, Asset, Athlete, Nutrient, Intellectual property, COVID-19, Dietary supplement

Great Neck Realty Co. is marketing the intellectual property (the “Assets”) of BOA Nutrition, Inc., (“Company” or “BOA”), an innovative sports nutrition and wellness company that specialized in producing oral aerosol energy supplements tailored to athletes and fitness enthusiasts of all ages and skill levels.

Key Points: 
  • Great Neck Realty Co. is marketing the intellectual property (the “Assets”) of BOA Nutrition, Inc., (“Company” or “BOA”), an innovative sports nutrition and wellness company that specialized in producing oral aerosol energy supplements tailored to athletes and fitness enthusiasts of all ages and skill levels.
  • Leveraging its OraBlast technology, BOA engineered products with atomized nutrients that are swiftly absorbed by the body.
  • The Company, which was launched in 2020 just prior to the COVID-19 pandemic, was unable to realize its full potential due primarily to supply chain issues that impacted manufacturing and distribution.
  • Those interested in learning more about the opportunity and sale process are encouraged to contact Great Neck Realty Co.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20240423801702/en/

Fresh Retail Software Industry Leader Invafresh Announces Appointment of Andrew Cron, PhD as Chief Data Officer

Retrieved on: 
火曜日, 4月 23, 2024
Technology, Electronic Commerce, Supermarket, Software, Food, Beverage, Retail, Supply Chain Management, Artificial Intelligence, Online Retail, Citadel, AI, Statistical Science, Hunger, Doctor of Philosophy, Citadel LLC, Duke University, SVP, MBA, CPG, Management

Invafresh, the industry leading fresh grocery platform, today announced Andrew Cron, PhD has joined the company as Chief Data Officer.

Key Points: 
  • Invafresh, the industry leading fresh grocery platform, today announced Andrew Cron, PhD has joined the company as Chief Data Officer.
  • He joins Invafresh from 84.51˚, Kroger’s retail data science, insights and media company, where he was SVP, Chief Scientist.
  • Prior to 84.51˚, Andrew held senior data scientist roles with Citadel LLC, Weinrub Analytics and MaxPoint.
  • Andrew holds a PhD in Statistical Science from Duke University and an MBA from Northwestern University’s Kellogg School of Management.

Capstone Green Energy Announces Mark Funaki as its General Counsel

Retrieved on: 
月曜日, 4月 22, 2024
Alternative Energy, Energy, Utilities, Corporation, Public policy, Capstone, General counsel, Annual report, Culture, Duke University, Vanderbilt University Law School, Senior, CUSIP, File, Management

Capstone Green Energy Holdings, Inc. (the “Company”), the public successor to Capstone Green Energy Corporation (Predecessor Capstone), is pleased to announce that Mark Funaki has been appointed as the Company’s General Counsel and Corporate Secretary.

Key Points: 
  • Capstone Green Energy Holdings, Inc. (the “Company”), the public successor to Capstone Green Energy Corporation (Predecessor Capstone), is pleased to announce that Mark Funaki has been appointed as the Company’s General Counsel and Corporate Secretary.
  • Prior to joining Capstone, Mark held roles of increasing responsibility at Jafra Cosmetics International, Inc., culminating with the position of Senior Vice President and General Counsel.
  • We welcome Mark and his acumen to the Capstone family,” said Vince Canino, Capstone’s President and Chief Executive Officer.
  • “I am honored to join Capstone and eager to contribute to the Company’s continued success,” said Mark Funaki.

Cytonus Therapeutics Expands C-suite as it Transitions to a Clinical Stage Company

Retrieved on: 
月曜日, 4月 22, 2024
Health, Infectious Diseases, Health Technology, General Health, Pharmaceutical, Biotechnology, Doctor of Philosophy, Administration, University, LEGO, Information, Master of Business Administration, M.B.A, Intellectual property, Commercialization, Partnering, McKinsey & Company, Business administration, Corporate development, Duke University, Senior, Patent, Bachelor of Arts, Virginia Tech, Medical school, Physician, Therapy, Management

Cytonus Therapeutics, Inc., a biotherapeutic company developing transformative medicines based on next generation drug-delivery platform technology called Cargocytes™, announced today that Mickey Kim, M.D., M.B.A. has joined the company as Chief Business Officer.

Key Points: 
  • Cytonus Therapeutics, Inc., a biotherapeutic company developing transformative medicines based on next generation drug-delivery platform technology called Cargocytes™, announced today that Mickey Kim, M.D., M.B.A. has joined the company as Chief Business Officer.
  • In addition, Cytonus has added Sherry M. Carty, Ph.D., as Director of Intellectual Property and Karen Markham has been promoted to Chief Administrative Officer.
  • Prior to Inova, he was a member of MedImmune/AstraZeneca's Partnering & Strategy Leadership Team, a healthcare venture capitalist and a strategy consultant with McKinsey and Company.
  • Mrs. Markham has been promoted to Chief Administrative Officer at Cytonus, where she oversees all administrative functions.

REV Group Appoints New Chief Financial Officer

Retrieved on: 
月曜日, 4月 15, 2024
Trucking, Aftermarket, Automotive, General Automotive, Transport, Automotive Manufacturing, Manufacturing, Recreational Vehicles, Performance & Special Interest, Corporation, CFO, Global information system, Illinois Wesleyan University, Economics, Summa, Robert Plant discography, Duke University, REV Group, Manufacturing operations, Institute of Internal Auditors, New product development, Caterpillar, Multimedia, Accounting, REV, REVG, Certified Public Accountant, Management

REV Group, Inc. (NYSE:REVG), a leading manufacturer of specialty vehicles, announces Amy Campbell has joined the company as Chief Financial Officer, effective today.

Key Points: 
  • REV Group, Inc. (NYSE:REVG), a leading manufacturer of specialty vehicles, announces Amy Campbell has joined the company as Chief Financial Officer, effective today.
  • View the full release here: https://www.businesswire.com/news/home/20240415263342/en/
    REV Group, Inc. (NYSE:REVG), a leading manufacturer of specialty vehicles, announces Amy Campbell has joined the company as Chief Financial Officer, effective today.
  • (Photo: Business Wire)
    Prior to REV Group, Campbell served as CFO of ASC Engineered Solutions and CFO for BrandSafway’s Commercial and Industrial Division.
  • “Amy is an experienced and highly respected finance executive,” said Mark Skonieczny, CEO and President, REV Group.

Roivios Secures FDA Breakthrough Device Designation for JuxtaFlow® RAD, Showcases Pioneering Data at Society of Cardiovascular Anesthesiologists Annual Meeting

Retrieved on: 
金曜日, 4月 26, 2024
FDA, Kidney disease, Society, Nursing care plan, SCA, RAD, Food, Research, ICU, Breakthrough, Acute kidney injury, Duke University, Oxygen, Patient, Cardiopulmonary bypass, AKI

This landmark recognition, fueled by the encouraging outcomes of the BIPASS-AKI feasibility study , coincides with the unveiling of pioneering research at the Society of Cardiovascular Anesthesiologists (SCA) Annual Meeting.

Key Points: 
  • This landmark recognition, fueled by the encouraging outcomes of the BIPASS-AKI feasibility study , coincides with the unveiling of pioneering research at the Society of Cardiovascular Anesthesiologists (SCA) Annual Meeting.
  • The Breakthrough Device Designation emphasizes the JuxtaFlow® RAD's potential to profoundly change the treatment paradigm for patients facing kidney disease during cardiac surgery.
  • John Erbey, CEO of Roivios, reflected on the significance of this achievement saying, "Securing the Breakthrough Device Designation marks a crucial milestone for Roivios and underscores our dedication to advancing kidney health innovation.
  • For more information about Roivios and the JuxtaFlow® Renal Assist Device, please visit Roivios.com .

Kayne Anderson Rudnick Appoints Tyler Cantarano as Research Analyst

Retrieved on: 
木曜日, 4月 25, 2024
Citadel, Franklin Templeton Investments, Business administration, KAR, Business, History, Information technology, Lexington Partners, Rest, Duke University, Investment, Management

LOS ANGELES, April 25, 2024 /PRNewswire/ -- Kayne Anderson Rudnick (KAR), a leading investment management firm, announced today that Tyler Cantarano has joined the firm as a research analyst, reporting directly to KAR Head of Research, Todd Beiley.

Key Points: 
  • LOS ANGELES, April 25, 2024 /PRNewswire/ -- Kayne Anderson Rudnick (KAR), a leading investment management firm, announced today that Tyler Cantarano has joined the firm as a research analyst, reporting directly to KAR Head of Research, Todd Beiley.
  • Prior to KAR, Cantarano spent four years at Franklin Templeton, most recently serving as an equity analyst working on small cap and mid cap equity funds.
  • "We are pleased to welcome Tyler, whose career in equity research began in 2017, to our U.S. equity research team here at KAR," said Beiley.
  • "KAR's high quality-oriented investment approach is built on unique research processes, where Tyler will be a valuable addition."

Ferguson Partners Announces Graham R. Beatty as New President

Retrieved on: 
木曜日, 4月 25, 2024
Heidrick & Struggles, Real estate, University, UBS, Business, Growth, Entrepreneurship, Russell Reynolds Associates, Duke University, MBA, Philosophy, Organization, Partner, Management

NEW YORK, April 25, 2024 /PRNewswire/ -- Ferguson Partners (Ferguson), the leading talent management and strategic advisory firm for the global real assets industries, announced the appointment of Graham R. Beatty as President and nominee to the company's Board.

Key Points: 
  • NEW YORK, April 25, 2024 /PRNewswire/ -- Ferguson Partners (Ferguson), the leading talent management and strategic advisory firm for the global real assets industries, announced the appointment of Graham R. Beatty as President and nominee to the company's Board.
  • As President, Mr. Beatty will lead the growth of Ferguson's global executive recruitment practice and help build out both the company's international platform and its North American business.
  • He will report directly to William J. Ferguson, Co-Founder, Co-Chairman, and CEO of Ferguson Partners regarding the firm's advisory businesses and to the Board on enterprise matters.
  • "I'm excited to join the Ferguson team and help grow the platform at this critical juncture," adds Mr. Beatty.

ClimeCo Launches 4Nature, a Set of High-Profile, Large Scale Decarbonization, Biodiversity Restoration and Social Impact Projects in Unique Global Locations

Retrieved on: 
水曜日, 4月 24, 2024
Cloud, National Geographic, Climate change, Atlantic Forest, Nature, Seed, Biodiversity, EVP, Animal, Partnership, Ecology, Employment, Carbon, Plant, Duke University, Galápagos Islands, Environment, Soil, Ecology and Society, Doris Duke, Agriculture

BOYERTOWN, Pa., April 24, 2024 /PRNewswire/ -- ClimeCo, the leading global decarbonization and environmental solutions company, has launched ClimeCo 4Nature, a program that offers leading sustainability-focused companies an opportunity to invest in carefully selected nature-based projects that preserve and restore uniquely important habitats, biodiversity and local communities. Created in partnership with UPROAR, a conservation organization that supports global biodiversity solutions, the program allows one organization to serve as the sole sponsor of an entire project in an environmentally essential area of the world to maximize its positive impact.

Key Points: 
  • The first 4Nature project to be announced is in the Andean Cloud Forests of Colombia .
  • "Our landmark, one-of-a-kind and customizable nature-based solutions projects available through 4Nature offer the scale to expedite progress and demonstrate truly transformative environmental, economic and social benefits."
  • Additional project sites will be announced over time, but all will be located in global biodiversity hotspots, including the Galapagos Islands of Ecuador and the Atlantic Rainforest in Brazil.
  • ClimeCo is proud to add the unique 4Nature model to its expansive portfolio of diverse nature-based solutions.